FDA Approved: ORIAHNN — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

FDA approved a supplemental application for Oriahnn (elagolix, estradiol, and norethisterone) from AbbVie. This action confirms the regulatory clearance for the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• ORIAHNN (ELAGOLIX AND ESTRADIOL AND NORETHISTERONE)

Snippet

SUPPL AP for ORIAHNN (ELAGOLIX AND ESTRADIOL AND NORETHISTERONE)